Hansi Flick could turn to Barcelona's reserve team for defensive reinforcements ahead of their Champions League clash against PSG.
With Andreas Christensen already sidelined through injury, the German manager suffered another blow when both Eric Garcia and Jules Kounde picked up problems against Real Betis.
According to journalist Sergi Capdevila, young centre-back Alex Campos is emerging as the leading candidate to make the trip to Paris.
Barcelona currently have only five first-team defenders available, forcing Flick to consider alternatives from Barça Atletic.
Campos has impressed with his performances at the start of the season, putting himself in a strong position to earn an opportunity with the senior squad.

#league #andreas #eric

Paris Saint-Germain have a selection problem on the left of defence before their Champions League meeting with Barcelona: Nuno Mendes is injured, and Lucas Digne is the natural alternative against Lamine Yamal. Mundo Deportivo reported the situation on 19 October, describing Mendes as Luis Enrique's preferred answer to the Barcelona winger.
The timing matters for the Catalans, with Yamal in excellent form. His impact in Barcelona's comeback against Galatasaray underlined the threat PSG will need to manage on Tuesday.
Digne's recent outing against Strasbourg did little to strengthen his case. Mundo Deportivo **** sed the Frenchman's display in PSG's 3-1 defeat as laboured and lacking in decisiveness, and reported that Luis Enrique substituted him as he changed course after starting several reserves.
Lucas Digne playing for France. – Photo: Bryan Berlin / CC BY-SA 4.0
That leaves the coach weighing a natural replacement whose latest performance raised questions, rather than simply making a like-for-like switch without concern. Digne is also a former Barcelona player, having spent two seasons at the club from 2016 to 2018.

#mundo #luis

Barcelona manager Hansi Flick faces a defensive selection headache ahead of Tuesday's Champions League clash with Paris Saint-Germain, with injuries to Eric Garcia and Jules Kounde leaving him short of natural right-back options.
Garcia is expected to miss three to four weeks with a muscle injury, while Kounde has been ruled out of the trip to the Parc des Princes with an ankle sprain.
Their simultaneous absences leave Flick needing to reshape his defence for one of Barcelona's biggest tests of the season.
On that note, the likes of Xavi Espart and Joao Cancelo are the leading alternatives at right-back, although neither has played regularly in that position this season.
For now, Mundo Deportivo explains that the likely solution could see the academy graduate deployed on the right, with the more experienced Cancelo filling in on the opposite flank.

#flick #garcia

Michael Dell, philanthropist and founder of Dell Technologies, pushed back against critics who argue that allowing wealthy investors to donate individual company stocks to Trump Accounts could have a nefarious impact.
Under new rules that took effect last week, charities can put individual stocks into kids' accounts as a donation. Trump Accounts are tax-advantaged investment vehicles that can be used for education expenses, starting a business, or saving for retirement. They were authorized in last year's One Big Beautiful Tax bill. Previously, the money was required to be invested in low-cost index funds.
Read more: Trump Accounts expand to stock donations. What are the benefits and risks?
So far, ***** eX President Gwynne Shotwell is the only donor to announce a major stock contribution, pledging more than 2 million shares to benefit lower-income children ages 11 to 17 living in lower-income areas.
"It's kind of hard for me to believe that's a bad thing, right?" Dell said Wednesday in an interview with Yahoo Finance. "That these children are going to somehow be negatively influenced because they now have one share of ***** eX, but they didn't have before, right? The alternative is they didn't have it, right?"

#last #lower

Michael Dell, philanthropist and founder of Dell Technologies, pushed back against critics who argue that allowing wealthy investors to donate individual company stocks to Trump Accounts could have a nefarious impact.
Under new rules that took effect last week, charities can put individual stocks into kids' accounts as a donation. Trump Accounts are tax-advantaged investment vehicles that can be used for education expenses, starting a business, or saving for retirement. They were authorized in last year's One Big Beautiful Tax bill. Previously, the money was required to be invested in low-cost index funds.
Read more: Trump Accounts expand to stock donations. What are the benefits and risks?
So far, **** eX President Gwynne Shotwell is the only donor to announce a major stock contribution, pledging more than 2 million shares to benefit lower-income children ages 11 to 17 living in lower-income areas.
"It's kind of hard for me to believe that's a bad thing, right?" Dell said Wednesday in an interview with Yahoo Finance. "That these children are going to somehow be negatively influenced because they now have one share of **** eX, but they didn't have before, right? The alternative is they didn't have it, right?"

#accounts

NVDA and AAPL join MSFT to control 21% of the S&P 500, nearly double the prior three-stock record of 13% set in the 1980s.
SPY investors who also hold NVDA, AAPL, or MSFT directly are doubling up; TOPC caps each position at 3% as a concentration alternative.
Only 25% of S&P 500 stocks trade above their 50-day moving average, meaning the index's record high rests on historically thin participation.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
At the close on October 6, 2026, the S&P 500 finished at a record 7,818.93, up 0.58%. Three companies now account for an unusually large share of that level.

#nvda

Melyssa Ford spoke out in defense of Jasmine Guy after the actress was ridiculed for her looks amid the release of Netflix's A Different World.
In a video posted to her Instagram on Tuesday (Sept. 22), Ford called out "internet gangsters" for criticizing Guy, 64. "You internet gangsters get on my f**kingnerves," the Hot & Bothered host began, calling Guy "the latest woman to be picked apart for her age."
"Women cannot win for losing," Ford said. "If a woman gets work done, she lacks self-love, she's insecure, she's chasing youth. If she doesn't, she's letting herself go or she's praised for being 'brave' for letting her face do what faces do. 'Brave' for aging."
Ford called "aging naturally" a "privilege," while the alternative is "death." "If you wanna die and live a good-looking corpse, that's on you. But most of us wanna live long, healthy, robust lives and that means getting older. No one calls a f**kingman 'brave' for going gray."
COMPLEX SHOP: Shop the brands you love, anytime and anywhere. Uncover what's next. Buy. Collect. Obsess.

#called #internet #woman #letting

PUBLISHED
OCT 03, 2026 AT 07:38 PM EDT
Tennessee officials are still investigating why death row inmate Christa Pike survived an execution attempt after receiving two doses of pentobarbital, a drug intended to render a person unconscious and ultimately cause death.
While the immediate focus has been on what went wrong inside the execution chamber, experts say Pike's case has also renewed scrutiny of a problem that has been building for more than a decade: how states obtain lethal injection drugs after pharmaceutical companies moved aggressively to keep their products from being used in executions. Despite those efforts, pentobarbital remains the primary execution drug used by many death-penalty states, making questions about sourcing, testing and oversight especially significant.
The issue has reshaped how many states carry out executions, forcing them to change drug protocols, seek alternative suppliers and adopt increasingly secretive procurement practices.

#pentobarbital #executions #published #tennessee

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."
Jennifer Lawrence is back with another dose of style inspo, and this time, she's bringing her summer favorites into fall.
Stepping out in New York City on Friday, October 2, the Hunger Games lead headed to dinner with a friend, wearing an autumnal take on one of the sunny season's go-to footwear choices: the classic flip flop.
BACKGRID
Throughout the heat-wave months, stars such as Kylie Jenner, Hailey Bieber, and Katie Holmes turned to Khaite and Gianvito Rossi for '90s-inspired flip flop heels with delicate kitten stilettos. And elsewhere, Kendall Jenner, Zoë Kravitz, Rosé, and fellow minimalist It girls lived in barely-there thong flip flops from the Row. But for the fall, Lawrence selected a chunkier, sturdier alternative: a black pair with wide straps and a comfy platform base that offered a bit of elevation from the NYC streets.

#magazines #stepping #york

Heidi Klum's youngest daughter put on a scene-stealing display in Paris when she stepped out with her mom for a rare photo opportunity.
The 17-year-old looked radiant as she held hands with Heidi and beamed for the cameras.
Lou — who rarely makes public appearances — wore a corseted waistcoat and mini-skirt which she teamed with stacked, co-ordinated heels.
Heidi and Lou during Heidifest (@ Getty Images)
Her long, curly hair was worn loose around her shoulders while Heidi also looked stylish in an alternative white suit.

#youngest

The failed execution of Christa Pike in Tennessee on Wednesday has added new fuel to the longstanding debate over the death penalty in the United States. It has also drawn new scrutiny to the question of whether lethal injection, the nation's primary method of execution for the past 40 years, is truly a "more humane" alternative to other ways of putting someone to death.
Pike was given a death sentence in 1996 after being convicted of killing her classmate, Colleen Slemmer, in an attack she carried out with her then boyfriend. After 30 years on death row, and a last-minute legal battle that temporarily delayed her execution, Pike was scheduled to be put to death on Wednesday night.
However, the two doses of pentobarbital she was given proved not to be fatal. According to witnesses, Pike remained alive and snored loudly for 40 minutes after the drugs were administered. Eventually, the execution was called off and she was taken to the hospital for treatment.
Pike's attorney Randy Spivey reported Thursday afternoon that she was in critical condition and receiving "life-saving care." She was unconscious and placed on a ventilator in the hospital, according to a filing by her legal team on Friday.
Spivey admonished the state for going forward with lethal injection despite his warnings ahead of time that a blood-clotting disorder called thrombocytosis "would cause her to suffer an agonizing death." Pike's attorneys had asked the courts to permit her to die by hanging, but the request was denied.

#pike #years #given

Léa Seydoux has turned her relationship with Louis Vuitton into one of the most recognizable partnerships on the red carpet. The French actress became an ambassador for the fashion house in 2016, and its designs have accompanied her to film festivals, premieres and major awards ceremonies ever since. Her wardrobe can move from sharp tailoring to elaborate crystal covered gowns without losing its distinctive character. Classic French elegance remains at the center, but unexpected shapes, textures and details keep the looks contemporary. Over the years, Seydoux has shown just how versatile a long term relationship between an actress and a fashion house can become.
At the 2018 Cannes Film Festival, Seydoux demonstrated that versatility through several contrasting looks. For the premiere of Under the Silver Lake, she selected an off the shoulder Louis Vuitton column gown featuring a bold geometric pattern. At the screening of Girls of the Sun, she wore another fitted design with a high slit and dramatic neckline. That appearance carried additional significance as Seydoux joined dozens of women on the Cannes steps in a demonstration calling attention to gender inequality within the film industry.
Returning to Cannes in 2019 for Oh Mercy!, Seydoux moved away from the traditional evening gown. Tailored blue trousers, a fitted printed top and a defined waist created a polished alternative to conventional premiere dressing. Red lipstick and Chopard jewelry completed a look that felt sophisticated without relying on elaborate volume.
Her formalwear became increasingly dramatic at subsequent events. At the 2020 Academy Awards, Seydoux appeared in a sculptural white Louis Vuitton gown with a plunging neckline and heavily pleated skirt. For the Vanity Fair celebration afterward, she changed into a flowing red dress. At the 2021 premiere of No Time to Die, she embraced even greater spectacle in a shimmering silver Louis Vuitton cape gown covered with crystals.
The 2022 BAFTA Awards produced another intricate creation. Seydoux wore a strapless black velvet Louis Vuitton gown with a sparkling embellished skirt, continuing her preference for silhouettes that combine simple lines with labor intensive detailing.

#seydoux #cannes #premiere

Italian beauty Monica Bellucci proved that age was just a number in a new photoshoot that showcased her modeling prowess as well as her ageless visage.
The 62-year-old looked beautiful in a series of photos taken for Harper's Bazaar España, which included a shot of her in a figure-hugging red gown, a picture of her sitting on a chair with her long legs on full display, and a snap of her in a backless black gown with a daring thigh slit.
Monica got candid about aging in the spotlight in the accompanying interview, revealing that she was not afraid of growing older, but rather viewed it as "a wonderful gift".
"There's no real alternative: either you grow old and accept the process with dignity, or you die. Looking at it that way, I'd much rather grow old," she explained.
Monica shared that aging was "a wonderful gift" (@ Getty Images)

#gown #grow #bellucci

On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion of its own stock during the quarter. But the profit story has moving parts, and a few of them pull in opposite directions.
Start with the gap between profit growth and sales growth. Adjusted operating income rose 17.0% while revenue grew only 5.1%. Much of the help came from gross profit, which jumped 23.2% on an adjusted basis as both segments contributed and the OneOncology acquisition in February lifted margins in the US business. In plain terms, adjusted gross margin widened 61 basis points to 4.16%, so the company keeps more gross profit from every dollar it sells.
The strength was not confined to one corner, either. US Healthcare Solutions grew operating income 15.9% on higher pharmaceutical sales and the OneOncology deal, while specialty volume to health systems and physician groups lifted its revenue. International Healthcare Solutions did better still, with operating income up 20.8% on strength in European distribution and global specialty logistics. Management also put cash to work, completing in one quarter the $1 billion of buybacks it had expected to finish by the close of calendar 2026. The board declared a $0.60 quarterly dividend as well, payable August 31, to holders of record on August 14.
Growth is costing more than it first appears. Adjusted operating expenses jumped 26.8%, faster than adjusted gross profit, because OneOncology brought expenses along with its profits. Even so, adjusted operating income amounts to just 1.46% of revenue, a thin cushion on a business this large. Financing adds weight too. Cencora funded part of the purchase with new senior notes plus variable-rate term loans, and net interest expense rose $58.9 million from a year earlier.
The sales mix carries its own drag. GLP-1 drugs for diabetes and weight loss are adding to revenue, but they earn lower gross margins, so each dollar of that growth is worth less to profit. Meanwhile, an oncology customer Cencora lost in 2025, and lower sales to a large mail order customer both held back US revenue, as did lower manufacturer prices on some brand pharmaceuticals. Cencora is also exploring strategic alternatives for a group of other businesses, and its April divestiture of US Consulting Services trimmed consulting sales.

#adjusted #revenue #august

The transition toward renewable energy is creating massive opportunities for infrastructure providers. Eos Energy Enterprises (NASDAQ:EOSE) and GE Vernova (NYSE:GEV) represent two distinct ways to play this trend in 2026.
Eos focuses on specialized zinc-based batteries for long-duration energy storage. GE Vernova is a diversified giant that services a massive portion of the world's electricity grid. Comparing these two helps clarify whether you prefer a high-growth disruptor or an established power leader.
Eos Energy Enterprises produces aqueous zinc batteries designed as a safer, scalable alternative to lithium-ion. It operates primarily within the industrial stocks **** e, targeting utilities and commercial developers. Customer concentration like this adds a layer of risk to the business, as two clients accounted for approximately 70% of total revenue in 2025.
In FY 2025, revenue reached approximately $114.2 million. This represents growth of nearly 631.8% compared to the prior fiscal year. The company reported a pre-tax net loss of roughly $969.6 million, resulting in a negative net margin of approximately 849.1%.
As of its December 2025 balance sheet, the company had a debt-to-equity ratio of -1.0x. This value indicates that total liabilities exceed shareholder equity. The current ratio, which measures the ability to cover short term obligations with short term **** ets, was approximately 4.9x, while free cash flow was nearly negative $265.0 million.

#enterprises #massive #Growth

Transocean Ltd. (NYSE:RIG) received a boost on September 15 when the company announced that it had secured an approximately $80 million contract for its Deepwater Conqueror ultra-deepwater drillship in Equatorial Guinea. The estimated 170-day campaign with an undisclosed operator is expected to begin next year, directly following the rig's current contract in the US Gulf.
Built in 2016, the DSME 12000-design Deepwater Conqueror can operate in water depths of up to 12,000 feet and drill to a maximum depth of 40,000 feet.
The $80 million award provides Transocean with additional contract revenue and improves visibility into the company's future revenue base. If the award includes attractive day rates and limited mobilization costs, it could contribute positively to operating margins and cash flows. The company's backlog stood at approximately $6.7 billion as of August 5, 2026.
The contract could also improve the utilization of its high-value drilling rig. Since ultra-deepwater rigs require substantial investment, securing work for an idle or underutilized rig could help spread fixed operating costs over a larger revenue base. Deepwater Conqueror will move directly from its US Gulf contract to Equatorial Guinea, avoiding a gap between the two programs.
The latest award also provides Transocean with an alternative destination for its rigs. The company had already signaled in its Q2 earnings call that the growing demand for new deepwater contracts in Africa would also help offset a decline in awards in the US Gulf.

#deepwater #contract #gulf #equatorial

Tempe, Arizona-based First Solar, Inc. (FSLR) is a leading photovoltaic (PV) solar technology and manufacturing company. The company develops and manufactures solar modules using its proprietary thin-film semiconductor technology, offering an alternative to conventional crystalline silicon PV modules. First Solar operates a global manufacturing network spanning the United States, India, Malaysia, and Vietnam. With a market cap of $21.6 billion, the company is one of the largest solar manufacturers.
Companies worth $10 billion or more are generally described as "large-cap stocks," and First Solar fits this description. The company is also one of the few major solar manufacturers with a significant U.S. manufacturing footprint, positioning it to benefit from domestic-content incentives and the broader push to expand U.S. solar manufacturing capacity. First Solar ended the second quarter with a contracted sales backlog of approximately 45.1 GW extending through 2030.
Bank of America Just Declared a 'Generational Entry Point' in U.S. Bonds. Why Investors Should Be Backing Up the Truck on Treasuries Here.
Mark Cuban Says He Was Dizzy for Months, So He Built a VR Fix That Does at Home 'Much Of What A 180k Machine' Does
JPMorgan Gives Up Forecasting Iran War Endgame as Trump Tells Reporters 'Anything Could Happen With Me'

#Solar #first #billion #tempe

On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion of its own stock during the quarter. But the profit story has moving parts, and a few of them pull in opposite directions.
Start with the gap between profit growth and sales growth. Adjusted operating income rose 17.0% while revenue grew only 5.1%. Much of the help came from gross profit, which jumped 23.2% on an adjusted basis as both segments contributed and the OneOncology acquisition in February lifted margins in the US business. In plain terms, adjusted gross margin widened 61 basis points to 4.16%, so the company keeps more gross profit from every dollar it sells.
The strength was not confined to one corner, either. US Healthcare Solutions grew operating income 15.9% on higher pharmaceutical sales and the OneOncology deal, while specialty volume to health systems and physician groups lifted its revenue. International Healthcare Solutions did better still, with operating income up 20.8% on strength in European distribution and global specialty logistics. Management also put cash to work, completing in one quarter the $1 billion of buybacks it had expected to finish by the close of calendar 2026. The board declared a $0.60 quarterly dividend as well, payable August 31, to holders of record on August 14.
Growth is costing more than it first appears. Adjusted operating expenses jumped 26.8%, faster than adjusted gross profit, because OneOncology brought expenses along with its profits. Even so, adjusted operating income amounts to just 1.46% of revenue, a thin cushion on a business this large. Financing adds weight too. Cencora funded part of the purchase with new senior notes plus variable-rate term loans, and net interest expense rose $58.9 million from a year earlier.
The sales mix carries its own drag. GLP-1 drugs for diabetes and weight loss are adding to revenue, but they earn lower gross margins, so each dollar of that growth is worth less to profit. Meanwhile, an oncology customer Cencora lost in 2025, and lower sales to a large mail order customer both held back US revenue, as did lower manufacturer prices on some brand pharmaceuticals. Cencora is also exploring strategic alternatives for a group of other businesses, and its April divestiture of US Consulting Services trimmed consulting sales.

#profit #operating #Growth #august

QQQI holders forfeited roughly $11 per share in total return versus QQQ over 31 months, equal to about $2,194 on a $10,000 stake.
Nearly 99% of QQQI's 2025 distributions were return of capital, meaning investors received their own money back, not income, with a shrinking cost basis.
QQQM and JEPQ serve as alternative ways to access the same underlying index.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
Every month, a NEOS Nasdaq-100 High Income ETF (NASDAQ:QQQI) holder gets a distribution check. In August 2026, it was $0.6518 per share. The annualized forward rate sits at $7.8216. The check feels like income, but the total-return record tells a different story. Since QQQI's first ex-dividend date, holders have quietly foregone roughly $10.97 per share in total return compared to a matching Nasdaq-100 position that costs a fraction to own.

#high

US stocks rebounded on Thursday as oil prices edged lower and a Fed rate hike on Wednesday offered some relief that the central bank was working to contain inflation.
The Dow Jones Industrial Average (^DJI) rose 0.6%, while the S&P 500 (^GSPC) climbed 1.1%. The tech-heavy Nasdaq Composite (^IXIC) jumped 1.7%, rebounding from a post-Fed-hike slump on Wednesday.
Stocks recovered as investors **** sed Federal Reserve Chairman Kevin Warsh's hawkish rhetoric, which **** ysts said helped restore the Fed's credibility on inflation. On Wednesday, the Federal Reserve raised interest rates by 25 basis points for the first time in three years and projected one more rate hike this year.
The decision drew the ire of President Trump, who called for lower interest rates and said he had spoken with Warsh ahead of the FOMC meeting. "You might as well vote with the board because it's not going to matter," Trump said he told Warsh.
Oil prices, meanwhile, ticked lower as US Energy Secretary Chris Wright said Saudi Arabia's East-West pipeline, which has become a key alternative route for oil stuck in the Strait of Hormuz, would be restored soon. Brent crude (BZ=F), the global benchmark, changed hands at $104 per barrel.

#reserve #Trump

On September 2, 2026, Phreesia, Inc. (NYSE:PHR) reported second-quarter fiscal 2027 results for the period ended July 31, 2026. Revenue rose 10% to $129.5 million and adjusted EBITDA climbed to $32.9 million from $22.1 million a year earlier, a 25% margin. Net income reached $1.9 million, marking the company's fifth consecutive quarter of profitability. Management reaffirmed full-year revenue guidance of $510 million to $520 million and adjusted EBITDA of $125 million to $135 million.
The disagreement on Wall Street is about what that reaffirmation actually signals.
Wells Fargo found the highlight in Network Solutions, which grew 9% year-over-year, and pointed to the ProviderConnect pilot delivering a 4% prescription lift in a GLP-1 campaign that management says is generating follow-on business; the firm raised its target on Phreesia, Inc. (NYSE:PHR) to $10 from $9 while holding an Equal Weight rating.
DA Davidson stayed at Buy despite trimming its target on Phreesia, Inc. (NYSE:PHR) to $13 from $14, arguing the stock sold off on a reiterated guide even though network solutions activity is tracking more encouragingly than the prior outlook and AccessOne is opening a growing opportunity in alternative consumer payment options.
Baird ******* yst Joe Vruwink lifted his target to $11 from $10 at Neutral after updating his model.

#million #solutions

Realty Income Corporation (NYSE:O) announced on September 14 a European property venture in which capital accounts advised by KKR & Co. Inc. (NYSE:KKR) intend to invest €528 million for a 49% interest. Closing is expected September 30, subject to customary conditions.
Realty Income Corporation (NYSE:O) would receive approximately €528 million in gross proceeds while retaining 51% ownership and day-to-day ******* et management. The contributed portfolio carries a 5.9% effective initial capitalization rate after recurring management fees. The question is whether redeploying the capital and earning fees can more than offset the rental economics transferred to the partner.
The venture could provide another funding source for acquisitions. Selling a minority interest in existing properties can release capital while preserving operational continuity. It also gives management an alternative when public equity or debt financing offers less attractive terms.
Management fees add a second source of income alongside retained property earnings. Realty Income Corporation (NYSE:O) could use its existing European operating platform to manage the venture, potentially spreading overhead across a broader pool of investor capital. The benefit depends on fee revenue exceeding the incremental costs of providing those services.
The structure includes a further source of potential upside. Realty Income Corporation (NYSE:O) would have an option to redeem the partner's interest after year 10 and through year 17. The redemption price would provide a capped internal rate of return, an annualized return accounting for cash-flow timing, expected at 6.3% to 6.5% and finalized at closing.

#NYSE #corporation #management #source

Updated Sept. 17, 2026 2:46 pm ET
Listen
(3 min)
1443 ET – Precious metal futures settle higher in New York, recovering from a swoon in the wake of yesterday’s Federal Reserve interest-rate increase. “My sense is that they will lag while we’re in a rate-hiking cycle, and right now we’re fairly clearly in a rate-hiking cycle,” says David Russell, global head of market strategy at TradeStation. There are a lot of arguments in favor of gold, in terms of central bank buying and an alternative to the dollar, but the current macro environment “is not in any way textbook favorable for gold and silver,” he adds. Front-month gold settles up 0.3% to $4,360.20 a troy ounce, and silver rises 1.8% to $65.47 a troy ounce. (anthony.harrupwsj.com)
1118 ET – Gold futures recover losses that followed the Fed’s rate hike as Treasury yields move lower and the dollar slips, while oil prices extend their pullback to a second day. “Gold is rangebound with two-way risk, but the large bull market we had seen earlier in the year is considered on pause for now,” Pepperstone strategist Ahmad ******* iri says in a note. The bull market could continue at some stage with underlying drivers such as central bank demand, macro uncertainty, and fiscal concerns, he says. But “the path of oil prices and their transmission into Fed policy remains the single most important variable from now till year-end.” The December contract is up 0.4% in New York at $4,404.90 a troy ounce. Silver rises 2.3% to $66.44 a troy ounce. (anthony.harrupwsj.com)

#Gold #york #futures

Interested in The Goldman Sachs Group, Inc.? Here are five stocks we like better.
Goldman Sachs expects its revenue base to reach roughly $70 billion this year, up from the mid-$30 billion range when its strategic plan began in 2018–19, supported by greater diversification and operating leverage.
Asset & Wealth Management is exceeding its targeted high-single-digit growth rate, overseeing about $4 trillion in ******* ets and targeting 30% margins and high-teen returns. Acquisitions and partnerships are expanding its alternatives, ETF, retirement and real estate capabilities.
Goldman expects alternatives fundraising above $125 billion this year and sees major financing opportunities from AI infrastructure investment, while near-term results may face higher expenses, softer FICC activity and a muted investments line.
Digging for Value: Alpha Metallurgical Resources Insider Buys Big

#year #here

Saudi Arabia's oil supply crisis is rapidly becoming Europe's problem.
The September 10 attacks on Saudi Arabia's East-West Pipeline struck the system at multiple locations and damaged at least one pumping station, forcing Riyadh to shut down the Kingdom's critical alternative to the Strait of Hormuz.
The 1,200-kilometer Petroline can carry around 7 million barrels per day from Saudi Arabia's eastern producing regions to Yanbu on the Red Sea. Since the war effectively closed Hormuz, it has become one of the most important pieces of energy infrastructure in the world.
Kpler estimates the pipeline had been moving roughly 4 million bpd around Hormuz before the attack. A prolonged outage could ultimately threaten 3.5–4 million bpd of Saudi crude exports. The figure is below Petroline's nameplate capacity because Saudi Arabia can still export some crude from eastern terminals such as Ras Tanura, despite the severe constraints on Gulf shipping.
The immediate problem is storage.

#hormuz #crude

This story was originally published on CRE Daily. Join 70,000+ commercial real estate professionals getting daily news, market insights, and industry ***** ysis delivered straight to their inbox with the free CRE Daily newsletter.
Tech leased 1.1 million square feet of New York office ***** e in Q3 so far, surpassing legal to become the market's second-largest leasing sector behind finance.
AI companies are driving roughly 60% of tech leasing this quarter, competing for ***** e as Manhattan office supply hits its lowest point since 2020.
Flatiron remains the top tech submarket, while Hudson Square, the Penn District and Downtown are emerging as alternatives for ***** e-constrained tenants.
New York's tech sector has overtaken legal to become the city's second-largest office sector, trailing only finance, according to a September JLL report cited by GlobeSt.com. Tech tenants have leased 1.1 million square feet across the metro so far in the third quarter, a pace JLL Managing Director Joe Sipala called one of the "busiest summers" for office leasing the brokerage has seen in some time.

#daily #square #sector

Boston, Massachusetts-based State Street Corporation (STT) provides a range of financial products and services to institutional investors. Valued at a market cap of $50.9 billion, it offers custody, accounting, and fund administration services for traditional and alternative ****** ets, as well as multi-asset-class investments, recordkeeping, client reporting, and more.
Companies with a market cap of $10 billion or more are typically referred to as "large-cap stocks." STT fits squarely in that category, with a market cap above this threshold that reflects its size and influence in the ****** et management industry.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Nvidia CEO Jensen Huang Just Dropped Huge News for This Cybersecurity Stock

#market #street

Self-driving tech company May Mobility has reached a deal to go public via a merger with a **** affiliated with Atlas Credit Partners.
Why it matters: The deal is a test of public-market appetite for autonomous vehicle companies, with May pitching investors on a relatively capital-light alternative to the fleet-owning robotaxi model.
Driving the news: The transaction with ACP Holdings Acquisition Corp. implies a $1.4 billion pro forma enterprise value and could provide the Ann Arbor, Mich.-based AV startup with up to $337 million in gross proceeds.
That includes $217 million from the **** 's trust, **** uming no redemptions, plus a $120 million fully committed from private investors through a so-called PIPE financing.
An Atlas Credit Partners affiliate is co-anchoring the PIPE.

#driving #deal

You can find original article here WealthManagement. Subscribe to our free daily WealthManagement newsletters.
Columbia Threadneedle Investments and alternative ******* et manager Hamilton Lane announced a strategic collaboration to deliver new investment products for the wealth channel. An interval fund combining public and private equity exposure, currently awaiting SEC approval, will likely be the first product launched through the two firms' partnership.
Columbia Threadneedle brings its public markets expertise, multi-asset investment capabilities and strategic distribution relationships to the collaboration. Hamilton Lane specializes in alternatives, with an established private markets platform, investment sourcing capabilities and data ******* ytics expertise.
Columbia Threadneedle filed a preliminary registration statement with the SEC for the Columbia Hamilton Lane Growth Innovation Fund, a public-private growth equity interval fund. If the fund is approved by the SEC, it will be offered to the wealth channel through financial advisors.
According to the filing, the fund will focus on capital appreciation, allocating at least 80% of its net ******* ets to investments in growth innovation companies. The fund will be roughly evenly split in exposure to publicly traded securities and private ******* ets. At least 40% of the fund's ******* ets will be invested in underlying funds managed by Hamilton Lane.

#lane

By Siddharth Cavale
NEW YORK, Sept 15 (Reuters) - Oil prices settled $3 higher on Tuesday after shipping industry sources said crude loadings at Saudi Arabia's Red Sea export hub of Yanbu had been suspended and Riyadh had canceled some cargo deliveries to European customers, deepening concerns that disruptions to a critical oil-export route ‌could persist for weeks.
Gains in U.S. West Texas Intermediate crude futures outpaced Brent on Tuesday, as fears that Saudi Arabia's supply troubles were widening sent investors rushing ‌into U.S. crude as an alternative.
Brent finished up $3.07, or 2.9%, at $108.75 a barrel, while WTI closed up $4.44, or 4.38%, at $105.83 a barrel. Both contracts closed at their highest since May 19.
The port of Yanbu has taken on outsized importance for global supply since the U.S.-Israeli war on Iran caused the closure of the Strait of Hormuz, a critical waterway that was the conduit for one-fifth of the world's oil and liquefied natural gas supplies.

#brent